Summary
The cardiovascular effects of four yohimbine diastereoisomers, yohimbine, rauwolscine, corynanthine, and 3-epi-α-yohimbine, were compared in urethane-anaesthetized and conscious, normotensive Sprague-Dawley rats. Intravenous cumulative infusions (10–500 μg) of the drugs to anaesthetized rats decreased blood pressure and blunted the pressor response to intravenous adrenaline injections. Corynanthine was the most potent isomer in this regard, followed by yohimbine, rauwolscine, and 3-epi-α-yohimbine. Depressor responses following intravenous bolus doses (40 μg) showed a similar ranking. Intraventricular injections of yohimbine to anaesthetized rats decreased blood pressure dose-dependently, as did injections of corynanthine and rauwolscine. Responses indicated the ranking to be yohimbine≥rauwolscine>corynanthine for this effect at the 40 μg dose. Heart rate was also decreased by these isomers, but not in a dose-dependent fashion. In conscious rats, the intraventricular injection of these isomers (20 μg) increased blood pressure and heart rate. No differences were noted in terms of blood pressure responses; but, in causing tachycardia, the ranking was rauwolscine>yohimbine>corynanthine. These data suggest that after intraventricular application in anaesthetized rats, the effects of these alpha-adrenoceptor blockers are related to their individual affinity for the alpha 2 adrenoceptor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berthelsen S, Pettinger WA (1977) A functional basis for classification of alpha-adrenergic receptors. Life Sci 21:595–606
Borowski KR, Finch L (1979) A comparison of the cardiovascular effects of centrally administered clonidine and adrenaline in the anesthetized rat. J Pharm Pharmacol 31:16–19
Chatterjee A, Das Gupta SR, Werner G (1954) Central and peripheral actions of two yohimbine isomers (serpine and rauwolscine). Indian J Med Res 42:613–617
Chen G, Nash LV, Russell D (1950) An evaluation of adrenergic blocking agents. Arch Int Pharmacodyn Ther 83:269–275
Ingram CG, Domino EF (1963) Observations on the initial hypertensive response to yohimbine. Arch Int Pharmacodyn Ther 143:534–542
Kohli JD, Bawani JH, Ray C, De NN (1957) Pharmacological action of rauwolscine: Part I-Adrenergic blocking activity. Arch Int Pharmacodyn Ther III:108–121
Lambert GA, Lang WJ, Friedman E, Meller E, Gershon S (1978) Pharmacological and biochemical properties of isomeric yohimbine alkaloids. Eur J Pharmacol 49:39–48
Lang WJ, Lamber GA, Rush ML (1975) The role of the central nervous system in the cardiovascular responses to yohimbine. Arch Int Pharmacodyn Ther 217:57–67
Nickerson M (1949) The pharmacology of adrenergic blockade. Pharmacol Rev 1:27–101
Raymond-Hamet (1925) Sur un nouveau cas d'inversion des effets adrenaliniques. Comp Rend Acad D Sc 180:2074–2077
Schmitt H, Schmitt H, Fenard S, (1973) Action of alpha-adrenergic blocking drugs and their interactions with central sympatho-inhibitory effect of clonidine. Arzneim Forsch 23:40–45
Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34:385–388
Tanaka T, Weitzell R, Starke K (1978) High selectivity of rauwolscine for presynaptic α-adrenoceptors. Eur J Pharmacol 52:239–240
Tangri KK, Bhargava KP (1961) Central component of vasomotor activity of yohimbine and its stereoisomer rauwolscine. Arch Int Pharmacodyn Ther 130:266–279
Timmermans PBNWM, Kwa HY, Zwieten PA van (1979) Possible subdivision of postsynaptic α-adrenoceptors mediating pressor responses in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 103:189–193
Weitzell R, Tanaka T, Starke K (1979) Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 308:129–136
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rockhold, R.W., Gross, F. Yohimbine diastereoisomers: Cardiovascular effects after central and peripheral application in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 315, 227–231 (1981). https://doi.org/10.1007/BF00499839
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499839